应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06826 昊海生物科技
休市中 11-13 16:08:15
15.520
-0.040
-0.26%
最高
15.640
最低
15.450
成交量
8.18万
今开
15.510
昨收
15.560
日振幅
1.22%
总市值
35.54亿
流通市值
5.40亿
总股本
2.29亿
成交额
126.81万
换手率
0.24%
流通股本
3,478万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
昊海生物科技11月9日回购9,100股H股,涉资约14.58万港元
公告速递 · 11-09
昊海生物科技11月9日回购9,100股H股,涉资约14.58万港元
昊海生物科技(06826)11月9日斥资14.58万港元回购9100股
智通财经 · 11-09
昊海生物科技(06826)11月9日斥资14.58万港元回购9100股
【券商聚焦】中信建投医疗器械和服务2027年投资策略:板块性机会逐渐显现
金吾财讯 · 11-06
【券商聚焦】中信建投医疗器械和服务2027年投资策略:板块性机会逐渐显现
股市必读:昊海生科新发布《上海昊海生物科技股份有限公司关于使用暂时闲置募集资金进行现金管理的公告》
证券之星 · 11-04
股市必读:昊海生科新发布《上海昊海生物科技股份有限公司关于使用暂时闲置募集资金进行现金管理的公告》
昊海生物科技更新2026年10月股份变动月报表,股本维持稳定
公告速递 · 11-03
昊海生物科技更新2026年10月股份变动月报表,股本维持稳定
股市必读:昊海生科新发布《上海昊海生物科技股份有限公司关于使用暂时闲置募集资金进行现金管理的公告》
证券之星 · 11-03
股市必读:昊海生科新发布《上海昊海生物科技股份有限公司关于使用暂时闲置募集资金进行现金管理的公告》
昊海生物科技再启闲置募资现金管理 额度不超2亿元
公告速递 · 11-02
昊海生物科技再启闲置募资现金管理 额度不超2亿元
昊海生物科技(06826)董事会批准最多2亿元闲置募资用于一年期现金管理
公告速递 · 11-02
昊海生物科技(06826)董事会批准最多2亿元闲置募资用于一年期现金管理
昊海生物科技(06826):11月2日回购4.6万股H股,耗资约74.08万港元
公告速递 · 11-02
昊海生物科技(06826):11月2日回购4.6万股H股,耗资约74.08万港元
昊海生物科技(06826)11月2日斥资约74.08万港元回购4.6万股
智通财经 · 11-02
昊海生物科技(06826)11月2日斥资约74.08万港元回购4.6万股
昊海生物科技(06826.HK)10月30日耗资约90.05万港元回购5.63万股
智通财经 · 10-30
昊海生物科技(06826.HK)10月30日耗资约90.05万港元回购5.63万股
昊海生物科技10月30日回购56,300股H股,涉资约90.05万港元
公告速递 · 10-30
昊海生物科技10月30日回购56,300股H股,涉资约90.05万港元
昊海生物科技:10月29日回购16,900股,耗资约27.11万港元
公告速递 · 10-29
昊海生物科技:10月29日回购16,900股,耗资约27.11万港元
昊海生物科技(06826)10月29日斥资27.11万港元回购1.69万股
智通财经 · 10-29
昊海生物科技(06826)10月29日斥资27.11万港元回购1.69万股
昊海生物科技:10月28日回购3.82万股H股,耗资约61.43万港元
公告速递 · 10-28
昊海生物科技:10月28日回购3.82万股H股,耗资约61.43万港元
昊海生物科技10月27日回购6.25万股H股,耗资约99.21万港元
公告速递 · 10-27
昊海生物科技10月27日回购6.25万股H股,耗资约99.21万港元
昊海生物科技(06826)10月27日耗资约99.21万港元回购6.25万股
智通财经 · 10-27
昊海生物科技(06826)10月27日耗资约99.21万港元回购6.25万股
昊海生物科技(06826)10月26日斥资55.89万港元回购3.5万股
智通财经 · 10-26
昊海生物科技(06826)10月26日斥资55.89万港元回购3.5万股
昊海生物科技回购3.5万股H股,总额约55.89万港元
公告速递 · 10-26
昊海生物科技回购3.5万股H股,总额约55.89万港元
昊海生物科技2026年三季度净利同比降逾四成 营收、现金流同步承压
公告速递 · 10-23
昊海生物科技2026年三季度净利同比降逾四成 营收、现金流同步承压
加载更多
公司概况
公司名称:
昊海生物科技
所属市场:
SEHK
上市日期:
--
主营业务:
上海昊海生物科技股份有限公司是一家主要从事生产及销售生物制品、医用透明质酸及人工晶状体、研发生物工程及药品及提供相关服务的中国公司。眼科业务已覆盖白内障治疗、近视防控与屈光矫正及眼表用药、提供人工晶状体及角膜塑形镜等产品的视光材料。医疗美容与创面护理产品覆盖玻尿酸真皮填充剂、皮肤和黏膜浅层组织补充用透明质酸凝胶等。骨科产品包含骨科关节腔黏弹补充剂等。防黏连及止血产品包括医用几丁糖(防黏连用)、医用透明质酸钠凝胶和胶原蛋白海绵。该公司主要在国内外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"昊海生物科技","latestPrice":15.52,"timestamp":1794557295594,"preClose":15.56,"halted":0,"volume":81800,"delay":0,"changeRate":-0.002570694087403658,"floatShares":34780300,"shares":229000000,"eps":1.2691073992421094,"marketStatus":"休市中","change":-0.04,"latestTime":"11-13 16:08:15","open":15.51,"high":15.64,"low":15.45,"amount":1268105,"amplitude":0.012211,"askPrice":15.59,"askSize":200,"bidPrice":15.52,"bidSize":173800,"shortable":0,"etf":0,"ttmEps":0.5588220657701692,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":7,"adr":0,"listingDate":1430323200000,"exchange":"SEHK","adjPreClose":15.56,"dividendRate":0.064448,"openAndCloseTimeList":[[1794533400000,1794542400000],[1794546000000,1794556800000]],"volumeRatio":3.21490332972372,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"昊海生科","latestPrice":28.61,"timestamp":1794553200000,"preClose":29.03,"halted":0,"volume":488200,"delay":0,"premium":"-53.84"}},"requestUrl":"/m/hq/s/06826","defaultTab":"news","newsList":[{"id":"1181258039","title":"昊海生物科技11月9日回购9,100股H股,涉资约14.58万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181258039","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181258039?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:35","pubTimestamp":1794216955,"startTime":"0","endTime":"0","summary":"2026年11月9日,昊海生物科技发布翌日披露报表,披露公司当日于香港联交所回购9,100股H股,占回购前公司已发行普通股总数224,984,100股的约0.004%。本次回购的每股价格介于15.88港元至16.03港元之间,合计涉资约14.58万港元。公司同时确认已遵守香港联交所上市规则及相关法律规定,公告由董事兼联席公司秘书田敏签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昊海生物科技11月9日回购9,100股H股,涉资约14.58万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682217805","title":"昊海生物科技(06826)11月9日斥资14.58万港元回购9100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682217805","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682217805?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:32","pubTimestamp":1794216759,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)发布公告,于2026年11月9日斥资14.58万港元回购9100股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681884015","title":"【券商聚焦】中信建投医疗器械和服务2027年投资策略:板块性机会逐渐显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2681884015","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681884015?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:57","pubTimestamp":1793926643,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,Q3多家公司业绩超预期、27年有望业绩改善,板块效应将逐步体现。重点关注2027年业绩增长及持续改善的公司,未来有望实现业绩估值双击。预计多个高值耗材和IVD板块的集采及降价政策影响将于年底或明年初逐步出清,板块性投资机会逐步凸显。医疗器械板块具有全球竞争力的改进式创新、突破式创新的产品正在被逐步认可,也有一批公司积极战略拓展第二增长曲线、实现海外业务高增长,估值迎来上涨。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995353","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","BK1610","HART","PTH","BK1617","BK1615","MEDX","LU0287142896.SGD","02190","BK1571","BK1584","BK1501","BK1585","RSPH","BK1593","BK0276","02252","BK1161","MDEV","GDOC","IEIH","06826","BK1591","BK1247","01302","02235","AGNG","00241","BK1222","601066","159883","01066","LGHT","BK1574","LU0173614495.USD","09996","BK1600","KCE","BK1515","BK1587","HK0000165453.HKD","BK1142","BK1583","00853","BK1100","BK1589","BK1502","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680711047","title":"股市必读:昊海生科新发布《上海昊海生物科技股份有限公司关于使用暂时闲置募集资金进行现金管理的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680711047","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680711047?lang=zh_cn&edition=full","pubTime":"2026-11-04 03:39","pubTimestamp":1793734749,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘,昊海生科报收于29.47元,上涨1.27%,换手率0.28%,成交量5421.0手,成交额1595.68万元。公司公告汇总:公司董事会审议通过使用不超过20,000万元暂时闲置募集资金进行现金管理,期限12个月,资金可循环滚动使用。公司公告汇总:截至2026年10月31日,累计1,135,200股已购回但尚未注销的H股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400004642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1593","BK0239","BK1161","688366","BK0251","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174392716","title":"昊海生物科技更新2026年10月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1174392716","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174392716?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:53","pubTimestamp":1793696023,"startTime":"0","endTime":"0","summary":"昊海生物科技于2026年11月3日发布2026年10月股份变动月报表,披露了公司在报告期内的股本结构与股份变动情况。截至2026年10月31日,公司已发行普通股包含H股与A股,注册股本合计228,832,195股,与上月保持一致。同时,公司报告提及此前已回购但截至本月尚未注销的合计1,135,200股H股,未对本月末的已发行股份数产生影响。报告还显示,2026年10月期间,无股份期权、权证、可转换债券等衍生工具的新增发行或行权,不存在股权激励计划的相关变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680767725","title":"股市必读:昊海生科新发布《上海昊海生物科技股份有限公司关于使用暂时闲置募集资金进行现金管理的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680767725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680767725?lang=zh_cn&edition=full","pubTime":"2026-11-03 03:34","pubTimestamp":1793648057,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘,昊海生科报收于29.1元,上涨1.18%,换手率0.3%,成交量5864.0手,成交额1685.34万元。公司公告汇总:昊海生科董事会审议通过使用不超过20,000万元暂时闲置募集资金进行现金管理,期限12个月,资金可循环滚动使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300005549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK1161","06826","BK0239","BK0251","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152116187","title":"昊海生物科技再启闲置募资现金管理 额度不超2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152116187","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152116187?lang=zh_cn&edition=full","pubTime":"2026-11-02 21:01","pubTimestamp":1793624463,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司11月2日公告,公司董事会审议通过议案,同意在不影响募投项目实施的前提下,使用不超过人民币20,000万元(含本数)的暂时闲置募集资金进行现金管理,期限自董事会审议通过之日起12个月内有效,资金可在额度内循环滚动使用。该次募集资金总额为人民币15.88亿元,扣除发行费用后净额为人民币15.29亿元,已全部存放于募集资金专项账户。董事会授权管理层在额度及期限内行使投资决策权,具体执行由财务部负责。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178614267","title":"昊海生物科技(06826)董事会批准最多2亿元闲置募资用于一年期现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=1178614267","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178614267?lang=zh_cn&edition=full","pubTime":"2026-11-02 20:55","pubTimestamp":1793624133,"startTime":"0","endTime":"0","summary":"2026年11月2日,昊海生物科技股份有限公司召开第六届董事会第十二次会议,通过《关于使用暂时闲置募集资金进行现金管理的议案》。公司计划自董事会审议通过之日起12个月内,使用不超过20,000万元的暂时闲置募集资金,购买安全性高、流动性好、带保本约定的投资产品,包括但不限于协定存款、通知存款、定期存款、大额存单及收益凭证等,资金可在额度内循环滚动使用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112806611","title":"昊海生物科技(06826):11月2日回购4.6万股H股,耗资约74.08万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112806611","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112806611?lang=zh_cn&edition=full","pubTime":"2026-11-02 18:02","pubTimestamp":1793613732,"startTime":"0","endTime":"0","summary":"2026年11月2日,上海昊海生物科技股份有限公司公告称,当日于香港联交所场内回购H股共46,000股,占公司现有已发行普通股总数约0.0204%。本次回购每股价格介乎港元15.90元至16.12元,总耗资约74.08万港元。根据披露,回购授权于2026年5月29日获股东大会批准,授权总数为3,478,034股。由于本次回购股份尚未注销,回购完成后公司H股数量仍为34,780,340股。公告同时确认本次回购已遵守相关上市规则和相关法律程序。该公告由公司董事兼联席公司秘书田敏签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"昊海生物科技(06826):11月2日回购4.6万股H股,耗资约74.08万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680585187","title":"昊海生物科技(06826)11月2日斥资约74.08万港元回购4.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680585187","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680585187?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:58","pubTimestamp":1793613516,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)发布公告,于2026年11月2日该公司斥资约74.08万港元回购4.6万股,回购价格为每股15.9至16.12港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679296485","title":"昊海生物科技(06826.HK)10月30日耗资约90.05万港元回购5.63万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679296485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679296485?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:22","pubTimestamp":1793352162,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158029450","title":"昊海生物科技10月30日回购56,300股H股,涉资约90.05万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158029450","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158029450?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:21","pubTimestamp":1793352080,"startTime":"0","endTime":"0","summary":"昊海生物科技于2026年10月30日公告回购股份。公司当日在香港联交所场内回购56,300股H股,占已发行股本约0.025%。回购价格区间介乎每股15.63港元至16.25港元,总金额为900,497港元,折合约90.05万港元。公司表示,本次回购股份尚未注销,故截至2026年10月30日,其H股已发行数量保持在34,780,340股不变。根据公告,昊海生物科技于2026年5月29日获得股东大会批准回购授权,回购股数上限为3,478,034股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"昊海生物科技10月30日回购56,300股H股,涉资约90.05万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143333241","title":"昊海生物科技:10月29日回购16,900股,耗资约27.11万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143333241","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143333241?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:07","pubTimestamp":1793264822,"startTime":"0","endTime":"0","summary":"2026年10月29日,昊海生物科技披露翌日披露报表,宣布于当日通过香港联交所场内回购16,900股H股,占公司目前已发行普通股总数224,984,100股的约0.0075%。每股回购价介乎港元16.00至16.10元,合计耗资约27.11万港元。本次回购尚未注销,完成后公司已发行股本暂未发生变动。根据公告,公司于2026年5月29日获股东大会批准可回购股份总数为3,478,034股,截至目前,已回购股份合计1,078,900股,占授权时已发行股份总数的3.102%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"昊海生物科技:10月29日回购16,900股,耗资约27.11万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679475841","title":"昊海生物科技(06826)10月29日斥资27.11万港元回购1.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679475841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679475841?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:57","pubTimestamp":1793264260,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)发布公告,于2026年10月29日,该公司斥资27.11万港元回购1.69万股股份,每股回购价16-16.1港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197364045","title":"昊海生物科技:10月28日回购3.82万股H股,耗资约61.43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197364045","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197364045?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:12","pubTimestamp":1793178732,"startTime":"0","endTime":"0","summary":"2026年10月28日,上海昊海生物科技股份有限公司发布公告称,公司当日于香港联交所场内回购H股38,200股,占现有已发行股本约0.017%。本次回购价格介乎每股15.97港元至16.10港元,合计支付约61.43万港元。公司于2026年5月29日获股东大会批准回购授权,可回购股份总数为3,478,034股,截至目前累计回购数量为1,062,000股,占授权时公司已发行股本约3.0534%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"昊海生物科技:10月28日回购3.82万股H股,耗资约61.43万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114624549","title":"昊海生物科技10月27日回购6.25万股H股,耗资约99.21万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114624549","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114624549?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:42","pubTimestamp":1793094142,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年10月27日公告称,当日通过香港联交所场内回购H股6.25万股,占公司截至目前约2.2498亿股已发行股份总数的0.0278%。本次回购价格区间为每股15.78港元至16.10港元,合计支付约99.21万港元。公司披露,截至10月27日,公司H股股本维持34,780,340股,A股股本为190,203,760股,另有3,848,095股A股处于库藏状态。公司同时确认,本次回购已获得董事会正式授权,并符合香港联合交易所证券上市规则及相关法律法规的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"昊海生物科技10月27日回购6.25万股H股,耗资约99.21万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678812731","title":"昊海生物科技(06826)10月27日耗资约99.21万港元回购6.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678812731","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678812731?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:39","pubTimestamp":1793093944,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)公布,2026年10月27日耗资约99.21万港元回购6.25万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678083163","title":"昊海生物科技(06826)10月26日斥资55.89万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678083163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678083163?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:56","pubTimestamp":1793005003,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生物科技(06826)发布公告,于2026年10月26日斥资55.89万港元回购3.5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170433533","title":"昊海生物科技回购3.5万股H股,总额约55.89万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170433533","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170433533?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:56","pubTimestamp":1793004960,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司于2026年10月26日公告称,当日通过香港联交所场内回购3.5万股H股,约占该公司当日现有已发行股份总数的0.0156%。此次回购每股价格介乎港币15.77元至16.00元,合计支付约55.89万港元。根据公告,本次回购所涉股份尚未注销,因此公司已发行股本暂未发生变动。截至本次回购完成后,公司H股股本维持34,780,340股不变;其A股股本为190,203,760股,并持有3,848,095股A股为库藏股,合并计算后的普通股总数为224,984,100股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"昊海生物科技回购3.5万股H股,总额约55.89万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162094563","title":"昊海生物科技2026年三季度净利同比降逾四成 营收、现金流同步承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1162094563","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162094563?lang=zh_cn&edition=full","pubTime":"2026-10-23 20:35","pubTimestamp":1792758956,"startTime":"0","endTime":"0","summary":"2026年10月23日,上海昊海生物科技股份有限公司披露截至2026年9月30日的第三季度报告。第三季度,公司实现营业收入5.31亿元,同比下降10.66%;实现利润总额0.55亿元,同比下降49.87%;归属于上市公司股东的净利润0.50亿元,同比下降46.28%;基本每股收益0.22元,同比减少45.00%。前三季度,公司营业收入为17.10亿元,同比下降9.93%;利润总额1.88亿元,同比下降45.68%;归属于上市公司股东的净利润1.63亿元,同比下降46.53%;扣除非经常性损益后的归母净利润1.16亿元,同比下降54.38%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3healthcare.com/","stockEarnings":[{"period":"1week","weight":-0.0306},{"period":"1month","weight":-0.0276},{"period":"3month","weight":-0.0572},{"period":"6month","weight":-0.2392},{"period":"1year","weight":-0.4162},{"period":"ytd","weight":-0.3271}],"compareEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.0278},{"period":"3month","weight":-0.0589},{"period":"6month","weight":-0.0896},{"period":"1year","weight":-0.1269},{"period":"ytd","weight":-0.0778}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海昊海生物科技股份有限公司是一家主要从事生产及销售生物制品、医用透明质酸及人工晶状体、研发生物工程及药品及提供相关服务的中国公司。眼科业务已覆盖白内障治疗、近视防控与屈光矫正及眼表用药、提供人工晶状体及角膜塑形镜等产品的视光材料。医疗美容与创面护理产品覆盖玻尿酸真皮填充剂、皮肤和黏膜浅层组织补充用透明质酸凝胶等。骨科产品包含骨科关节腔黏弹补充剂等。防黏连及止血产品包括医用几丁糖(防黏连用)、医用透明质酸钠凝胶和胶原蛋白海绵。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.002081},{"month":2,"riseRate":0.363636,"avgChangeRate":0.018834},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.014563},{"month":4,"riseRate":0.818182,"avgChangeRate":0.062966},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.022119},{"month":6,"riseRate":0.25,"avgChangeRate":-0.018495},{"month":7,"riseRate":0.583333,"avgChangeRate":0.058199},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.02166},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.014306},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.030487},{"month":11,"riseRate":0.5,"avgChangeRate":-0.009397},{"month":12,"riseRate":0.545455,"avgChangeRate":0.02266}],"exchange":"SEHK","name":"昊海生物科技","nameEN":"HAOHAI BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊海生物科技,06826,昊海生物科技股票,昊海生物科技股票老虎,昊海生物科技股票老虎国际,昊海生物科技行情,昊海生物科技股票行情,昊海生物科技股价,昊海生物科技股市,昊海生物科技股票价格,昊海生物科技股票交易,昊海生物科技股票购买,昊海生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊海生物科技(06826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊海生物科技(06826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}